Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Arch Pharm (Weinheim) ; 343(3): 133-42, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20186865

RESUMEN

Current evidences support the hypothesis that non-steroidal anti-inflammatory drugs (NSAIDs) and antioxidant therapy might protect against the development of Alzheimer's disease (AD). In the present work, our attention was focused on ibuprofen (IBU) used in clinical trails to prevent Alzheimer's disease, and (R)-alpha-lipoic acid (LA) considered as a potential neuroprotective agent in AD therapy. In particular, we investigated a series of lipophilic molecular combinations obtained by joining (R)-alpha-lipoic acid and ibuprofen via an amide bond. These new entities might allow targeted delivery of the parent drugs to neurons, where cellular oxidative stress and inflammation seem related to Alzheimer's disease. Our study included the synthesis of conjugates 1-3 and the evaluation of their physicochemical and in-vitro antioxidant properties. The new compounds are extremely stable in aqueous buffer solutions (pH = 1.3 and 7.4), and in rat and human plasma they showed a slow bioconversion to ibuprofen and (R)-alpha-lipoic acid. Codrugs 1-3 displayed in vitro free radical scavenging activity and were hydrolyzed more rapidly in brain tissue than in rat serum indicating that these new entities might allow targeted delivery of the parent drugs to neurons. The immunohistochemical analysis of Abeta (1-40) protein showed that Abeta-injected cerebral cortices treated with ibuprofen or compound 1 showed few plaques within capillary vessels and, in particular, Abeta (1-40) protein was less expressed in codrug-1-treated than in ibuprofen-treated cerebral cortex.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Ibuprofeno/uso terapéutico , Fármacos Neuroprotectores/síntesis química , Fármacos Neuroprotectores/uso terapéutico , Profármacos/síntesis química , Profármacos/uso terapéutico , Ácido Tióctico/uso terapéutico , Péptidos beta-Amiloides/metabolismo , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Antioxidantes/administración & dosificación , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Química Farmacéutica/métodos , Diamida/química , Modelos Animales de Enfermedad , Combinación de Medicamentos , Estabilidad de Medicamentos , Depuradores de Radicales Libres/síntesis química , Depuradores de Radicales Libres/farmacocinética , Depuradores de Radicales Libres/uso terapéutico , Ibuprofeno/química , Masculino , Fármacos Neuroprotectores/farmacocinética , Profármacos/farmacocinética , Ratas , Ratas Wistar , Ácido Tióctico/química
2.
Chem Biol Interact ; 182(2-3): 245-52, 2009 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-19772857

RESUMEN

Polymorphonuclear neutrophils are professional phagocytes whose efficacy depends on a multicomponent NADPH oxidase for generating superoxide anions and bacterial killing. They can be primed and activated by different agents that can impair oxidative burst and phagocytosis with opposite effects: reduced capability to destroy bacteria or hyperactivation that induces the generation of large quantities of toxic reactive oxygen species, which can damage surrounding tissue and participate in inflammation. The present study was designed to evaluate the effect of sub-chronic (60 days) permethrin treatment (1/10 DL(50)) on rat polymorphonuclear neutrophils respiratory burst. The results show that permethrin treatment increases superoxide anion production (33 times) and the activity of hydrogen peroxide-myeloperoxidase system (67 times). In vitro experiments suggest that this effect can be related to permethrin priming and to physico-chemical changes at the plasma membrane level of neutrophils. The antioxidant supplementation with Vitamin E and coenzyme Q(10) can protect against the abnormal respiratory burst in rat treated with permethrin. The in vitro studies show that neutrophil apoptosis begins soon after 1h of incubation with permethrin (0.725% of total cells) or its metabolites (3-phenoxybenzyl alcohol, 3-phenoxybenzaldehyde and 3-phenoxybenzoic acid 1.36, 2.26 and 1.3 of total cells, respectively) and that the level of apoptotic cells is very low. In conclusion, immunotoxicity of permethrin measured in rats could prompt future studies on the consequences of chronic insecticide exposure.


Asunto(s)
Insecticidas/farmacología , Neutrófilos/efectos de los fármacos , Permetrina/farmacología , Animales , Apoptosis/efectos de los fármacos , Degranulación de la Célula/efectos de los fármacos , Peróxido de Hidrógeno/metabolismo , Masculino , Fluidez de la Membrana/efectos de los fármacos , Neutrófilos/citología , Oxidación-Reducción/efectos de los fármacos , Ratas , Ratas Wistar , Superóxidos/metabolismo
3.
J Appl Toxicol ; 29(4): 317-22, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19153980

RESUMEN

Pyrethroids are widely used insecticides of low acute toxicity in mammals but the consequences of long-term exposure are of concern. Their insecticidal action is related to neurotoxicity and, in addition, there are indications of mammalian immuno-toxicity. In this work the effect of 60 days permethrin (150 mg kg(-1) body weight/day) exposure on two types of leukocytes (monocytes and lymphocytes) in adolescent rats was investigated. In particular, the monocyte respiratory burst response was first investigated, followed by studies on the degree and type of lymphocyte DNA damage induced by permethrin at this stage of life. Permethrin treatment reduces the monocyte respiratory burst response to phorbol myristate acetate, thereby decreasing superoxide anion (65%) and hydrogen peroxide (37%) production. Moreover an increase [correction made here after initial online publication] in monocyte plasma membrane fluidity in the hydrophilic-hydrophobic interface of the lipid bilayer was measured. Data obtained from the comet assay show that permethrin induces lymphocyte DNA lesions at both formamido pyrimidine glycosylase (Fpg) and endonuclease III (Endo III) sites in adolescent rats. Our results indicate the key role of permethrin in oxidative stress whose consequences lead to biochemical and functional changes. The reduced phagocyte respiratory burst induced by permethrin treatment and the type of DNA damage measured could represent new relevant aspects of pyrethroid toxicity which should be considered for human health.


Asunto(s)
Daño del ADN , ADN-Formamidopirimidina Glicosilasa/efectos de los fármacos , Desoxirribonucleasa HindIII/efectos de los fármacos , Insecticidas/toxicidad , Linfocitos/efectos de los fármacos , Permetrina/toxicidad , Estallido Respiratorio/efectos de los fármacos , Animales , Ensayo Cometa , ADN-Formamidopirimidina Glicosilasa/metabolismo , Desoxirribonucleasa HindIII/metabolismo , Masculino , Fluidez de la Membrana/efectos de los fármacos , Monocitos/efectos de los fármacos , Ratas , Ratas Wistar , Espectrometría de Fluorescencia
4.
J Med Chem ; 52(2): 559-63, 2009 Jan 22.
Artículo en Inglés | MEDLINE | ID: mdl-19093882

RESUMEN

A series of multifunctional codrugs (1-6) were synthesized to overcome the pro-oxidant effect associated with L-dopa (LD) therapy. Target compounds release LD and dopamine (DA) in human plasma after enzymatic hydrolysis, displaying an antioxidant effect superior to that of N-acetylcysteine (NAC). After intracerebroventricular injection of codrug 4, the levels of DA in the striatum were higher than those in LD-treated groups, indicating that this compound has a longer half-life in brain than LD.


Asunto(s)
Antioxidantes/uso terapéutico , Antiparkinsonianos/uso terapéutico , Levodopa/análisis , Enfermedad de Parkinson/tratamiento farmacológico , Azufre/análisis , Análisis de Varianza , Animales , Antioxidantes/química , Antioxidantes/farmacocinética , Antiparkinsonianos/química , Antiparkinsonianos/farmacocinética , Área Bajo la Curva , Cromatografía Líquida de Alta Presión , Cuerpo Estriado/metabolismo , Semivida , Humanos , Inyecciones Intraventriculares , Ratas , Espectrofotometría Ultravioleta
5.
Toxicology ; 251(1-3): 45-50, 2008 Sep 29.
Artículo en Inglés | MEDLINE | ID: mdl-18692543

RESUMEN

Pyrethroids are important insecticides used largely because of their high activity as an insecticide and their low mammalian toxicity. Some studies have demonstrated that these products show neurotoxic effects on the mammalian central nervous system. The aim of the present study was to investigate the propensity of permethrin to induce oxidative stress in adolescent rats and its possible attenuation by Vitamin E alone or+Coenzyme Q(10). Data indicated that adolescent rats exposed to permethrin exhibited alteration in the locomotor activity and plasma membrane fluidity of striatum. Vitamin E+Q(10) and Vitamin E alone supplementation reversed the negative effect on central nervous system. Permethrin alteration of striatum plasma membrane fluidity was restored by Vitamin E+Q(10). Data obtained from red blood cells showed that permethrin did not induce any modification of plasma membrane fluidity in adolescent rats, whereas antioxidants supplementation induced pro-oxidant effect. In summary some differences between antioxidant treatments were observed at striatum level: Coenzyme Q(10)+Vitamin E maintains plasma membrane fluidity, while Vitamin E is more effective to preserve GSH level.


Asunto(s)
Antioxidantes/farmacología , Cuerpo Estriado/efectos de los fármacos , Insecticidas/toxicidad , Fluidez de la Membrana/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Permetrina/toxicidad , Animales , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Cuerpo Estriado/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Síndromes de Neurotoxicidad/etiología , Síndromes de Neurotoxicidad/fisiopatología , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Ubiquinona/análogos & derivados , Ubiquinona/farmacología , Vitamina E/farmacología
6.
Arch Pharm (Weinheim) ; 341(7): 412-7, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18581391

RESUMEN

This paper reports the synthesis and preliminary evaluation of new L-dopa (LD) conjugates (1 and 2) obtained by joining LD with two different natural antioxidants, caffeic acid and carnosine, respectively. The antioxidant efficacy of compounds 1 and 2 was assessed by evaluating plasmatic activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx) in the rat. Rat striatal concentration of LD and dopamine (DA), and central nervous effects were evaluated after oral administration of the codrugs 1 and 2. The results suggest that, though our codrugs are devoid of significant antioxidant activity, they are able to induce sustained delivery of DA in rat striatum and can improve LD and DA release in the brain.


Asunto(s)
Antioxidantes/química , Antiparkinsonianos/farmacología , Levodopa/farmacología , Enfermedad de Parkinson/tratamiento farmacológico , Administración Oral , Animales , Antioxidantes/síntesis química , Antioxidantes/farmacología , Antiparkinsonianos/síntesis química , Antiparkinsonianos/química , Ácidos Cafeicos/química , Ácidos Cafeicos/farmacología , Carnosina/química , Carnosina/farmacología , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Glutatión Peroxidasa/metabolismo , Levodopa/química , Levodopa/metabolismo , Ratas , Superóxido Dismutasa/metabolismo
7.
J Med Chem ; 50(10): 2506-15, 2007 May 17.
Artículo en Inglés | MEDLINE | ID: mdl-17451233

RESUMEN

A series of novel molecular combinations (1-4), in which L-dopa (LD) is linked covalently via an amide bond with glutathione (GSH), were synthesized and evaluated as potential anti-Parkinson agents with antioxidant properties. These conjugates were characterized by evaluating solubility, chemical and enzymatic stabilities, and apparent partition coefficient (log P). Derivatives 2 and 4 were tested for their radical scavenging activities, by use of a test involving the Fe(II)/H2O2-induced degradation of deoxyribose. In this study, the antioxidant efficacy of codrugs 1 and 3 was also assessed through the evaluation of plasmatic activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx). Furthermore, the central nervous effects and rat striatal concentration of LD and dopamine (DA) have been evaluated after oral administration of codrugs 1 and 3. Tested compounds prolonged the plasma LD levels and were able to induce sustained delivery of DA in rat striatum with respect to an equimolar dose of LD. The results suggest that compounds 1 and 3 could represent useful new anti-Parkinson agents devoid of the pro-oxidant effects associated with LD therapy and potentially able to restore the GSH depletion evidenced in the substantia nigra pars compacta (SNpc) of PD patients.


Asunto(s)
Antiparkinsonianos/síntesis química , Depuradores de Radicales Libres/síntesis química , Glutatión/análogos & derivados , Glutatión/síntesis química , Levodopa/análogos & derivados , Levodopa/síntesis química , Administración Oral , Animales , Antiparkinsonianos/farmacología , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Depuradores de Radicales Libres/farmacología , Glutatión/farmacología , Glutatión Peroxidasa/metabolismo , Humanos , Hidrólisis , Técnicas In Vitro , Levodopa/farmacocinética , Levodopa/farmacología , Masculino , Actividad Motora/efectos de los fármacos , Ratas , Ratas Wistar , Solubilidad , Relación Estructura-Actividad , Superóxido Dismutasa/metabolismo
8.
Phytother Res ; 21(6): 587-8, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17397118

RESUMEN

We believe that administration of phytotherapics ('herbal' medicines) should be managed by physicians and pharmacists who can monitor any adverse reactions including allergies in patients. This of course implies that physicians and pharmacists require adequate training at the university and post-university level regarding all aspects of medicinal plants. We report here a case of paralytic ileum occurring in an older self-medicated patient who acquired an herbal tisane composed of Cassia angustifolia, as well as other plant products, in an herbal shop, for chronic constipation.


Asunto(s)
Seudoobstrucción Intestinal/inducido químicamente , Extractos Vegetales/efectos adversos , Senna/química , Anciano de 80 o más Años , Estreñimiento/tratamiento farmacológico , Humanos , Íleon/efectos de los fármacos , Íleon/patología , Seudoobstrucción Intestinal/patología , Masculino , Fitoterapia/efectos adversos , Extractos Vegetales/uso terapéutico
9.
Toxicology ; 229(3): 194-205, 2007 Jan 18.
Artículo en Inglés | MEDLINE | ID: mdl-17140720

RESUMEN

Pyrethroids are a class of insecticides involved in different neurological disorders. They cross the blood-brain barrier and exert their effect on dopaminergic system, contributing to the burden of oxidative stress in Parkinson's disease through several pathways. The aim of the present study was to evaluate the effect of neonatal exposition to permethrin and cypermethrin (1/10 of DL(50)) in rats from the eighth to the fifteenth day of life. Open-field studies showed increased spontaneous locomotor activity in the groups treated with permethrin and the one treated with cypermethrin, while a higher number of center entries and time spent in the center was observed for the cypermethrin-treated group. Lower dopamine and higher homovanillic acid levels were measured in the striatum from both treated groups. A reduction of blood glutathione peroxidase content was measured, while no change in blood superoxide dismutase was observed. Carbonyl group formation increased in striatum, but not in erythrocytes. Lipid peroxidation occurred in erythrocytes, but not in striatum. No changes in fluidity at different depths of plasma membrane were measured in striatum or erythrocytes. The activation of monocyte NADPH oxidase by phorbol esters (PMA) shows that superoxide anion production was reduced in the pyrethroid-treated groups compared to the control group. Our studies suggest that neonatal exposition to permethrin or cypermethrin induces long-lasting effects after developmental exposure giving changes in open-field behaviors, striatal monoamine level, and increased oxidative stress. Although the action of pyrethroids on various target cells is different, a preferential interaction with the extracellular side of plasma membrane proteins can be observed.


Asunto(s)
Cuerpo Estriado/efectos de los fármacos , Insecticidas/toxicidad , Permetrina/toxicidad , Piretrinas/toxicidad , Ácido 3,4-Dihidroxifenilacético/metabolismo , Animales , Animales Recién Nacidos , Membrana Celular/efectos de los fármacos , Membrana Celular/fisiología , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Eritrocitos/efectos de los fármacos , Eritrocitos/fisiología , Femenino , Glutatión/metabolismo , Glutatión Peroxidasa/sangre , Ácido Homovanílico/metabolismo , Masculino , Monocitos/efectos de los fármacos , Monocitos/metabolismo , Actividad Motora/efectos de los fármacos , Estrés Oxidativo , Ratas , Ratas Wistar , Estallido Respiratorio/efectos de los fármacos , Superóxido Dismutasa/sangre
10.
Environ Toxicol Pharmacol ; 23(2): 250-3, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21783765

RESUMEN

Since pyrethroids are involved in reactive oxygen species production and no investigations have yet been performed on smooth muscle cell integrity, we studied the influence of permethrin- and cypermethrin-treatment on rabbit aorta using confocal laser scanning fluorescence microscopy, which allows cell viability to be assessed within the wall of living rabbit aorta. The data obtained show that the pyrethroid-treatment (10-100µM) impairs the smooth muscle cell viability. A double-labeling protocol allowed us to distinguish cytotoxic effects of permethrin- and cypermethrin-treatment in aortic rings. In conclusion, permethrin seems to induce more oxidative stress on the aorta wall than that cypermethrin does.

11.
J Med Chem ; 49(4): 1486-93, 2006 Feb 23.
Artículo en Inglés | MEDLINE | ID: mdl-16480285

RESUMEN

A series of multifunctional codrugs (1-4), obtained by joining L-Dopa (LD) and dopamine (DA) with (R)-alpha-lipoic acid (LA), was synthesized and evaluated as potential codrugs with antioxidant and iron-chelating properties. These multifunctional molecules were synthesized to overcome the pro-oxidant effect associated with LD therapy. The physicochemical properties, together with the chemical and enzymatic stabilities of synthesized compounds, were evaluated in order to determine both their stability in aqueous medium and their sensitivity in undergoing enzymatic cleavage by rat and human plasma to regenerate the original drugs. The new compounds were tested for their radical scavenging activities, using a test involving the Fe (II)-H2O2-induced degradation of deoxyribose, and to evaluate peripheral markers of oxidative stress such as plasmatic activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx) in the plasma. Furthermore, we showed the central effects of compounds 1 and 2 on spontaneous locomotor activity of rats in comparison with LD-treated animals. From the results obtained, compounds 1-4 appeared stable at a pH of 1.3 and in 7.4 buffered solution; in 80% human plasma they were turned into DA and LD. Codrugs 1-4 possess good lipophilicity (log P > 2 for all tested compounds). Compounds 1 and 2 seem to protect partially against the oxidative stress deriving from auto-oxidation and MAO-mediated metabolism of DA. This evidence, together with the "in vivo" dopaminergic activity and a sustained release of the parent drug in human plasma, allowed us to point out the potential advantages of using 1 and 2 rather than LD in treating pathologies such as Parkinson's disease, characterized by an evident decrease of DA concentration in the brain.


Asunto(s)
Antioxidantes/síntesis química , Agonistas de Dopamina/síntesis química , Dopamina/química , Quelantes del Hierro/química , Levodopa/química , Ácido Tióctico/química , Animales , Antioxidantes/química , Antioxidantes/farmacología , Biomarcadores/sangre , Agonistas de Dopamina/química , Agonistas de Dopamina/farmacología , Estabilidad de Medicamentos , Depuradores de Radicales Libres/síntesis química , Depuradores de Radicales Libres/química , Depuradores de Radicales Libres/farmacología , Glutatión Peroxidasa/sangre , Humanos , Concentración de Iones de Hidrógeno , Hidrólisis , Técnicas In Vitro , Cinética , Levodopa/farmacología , Masculino , Actividad Motora/efectos de los fármacos , Estrés Oxidativo , Ratas , Ratas Wistar , Solubilidad , Estereoisomerismo , Relación Estructura-Actividad , Superóxido Dismutasa/sangre
12.
Ann Nutr Metab ; 49(1): 9-15, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15735363

RESUMEN

AIMS: The purpose of the present study was to evaluate the ability of calcic and magnesic-sulphate-sulphurous spring mineral water (SMW) to reduce total and erythrocyte plasma membrane cholesterol in rats fed a cholesterol-rich diet. METHODS: By using different fluorescent probes, 1,6-diphenyl-1,3,5-hexatriene (DPH), 1-[4-(trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene (TMA-DPH) and Laurdan, a possible correlation was evaluated between cholesterol content changes of the membranes and membrane fluidity. RESULTS: The results clearly show that hydropinic treatment reduced cholesterol level. No significant change was observed in DPH and TMA-DPH anisotropy values. By using Laurdan, an increase was observed in generalized polarization (GP(340)) in both groups of rats (the one that drank tap water and the one that drank SMW) compared with the controls. The rate of haemolysis was reduced in those erythrocyte suspensions in which cholesterol was increased, even if the enzymatic activity of glutathione peroxidase and catalase decreased. CONCLUSION: Hydropinic treatment with SMW is of interest from the biomedical point of view, because it could represent an alternative approach in interventions aimed at ameliorating biological injury deriving from hypercholesterolaemia.


Asunto(s)
2-Naftilamina/análogos & derivados , Colesterol en la Dieta/administración & dosificación , Colesterol/análisis , Difenilhexatrieno/análogos & derivados , Membrana Eritrocítica/química , Fluidez de la Membrana/efectos de los fármacos , Aguas Minerales/administración & dosificación , Animales , Colesterol/metabolismo , Colesterol en la Dieta/metabolismo , Polarización de Fluorescencia , Colorantes Fluorescentes , Lauratos , Masculino , Distribución Aleatoria , Ratas , Ratas Endogámicas
13.
Toxicology ; 203(1-3): 17-26, 2004 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-15363578

RESUMEN

Pesticides have been considered potential chemical mutagens. In fact, some studies show that various agrochemical ingredients possess mutagenic properties inducing mutations, chromosomal alterations or DNA damage. Experimental evidence shows a marked correlation between mutagenicity and carcinogenicity and indicates that short-term mutagenicity tests are useful for predicting carcinogenicity. The present study on rat exposed to two pyrethroids, cypermethrin and permethrin, showed different lymphocyte DNA damage depending on the type of pyrethroid, the dose, and the period of treatment. Data obtained from comet assay showed that oral treatment with 150 mg/kg body weight/day of permethrin (corresponding to 1/10 of LD50) for 60 days, induced a significant increase in all comet parameters. No lymphocyte DNA damage was measured after treatment with 25 mg/kg body weight/day of cypermethrin (corresponding to 1/10 of LD50) for the same period. A higher dose of permethrin (300 mg/kg body weight/day), for a shorter period (22 days), did not induce lymphocyte DNA damage, while supplementation with 200 mg/kg of Vitamins E and C protected erythrocytes against plasma membrane lipids peroxidation. Moreover, treatment with Vitamins E and C maintained the activity of glutathione peroxidase, which was reduced in the presence of permethrin, and reduced the osmotic fragility, which had increased following permethrin treatment.


Asunto(s)
Antioxidantes/uso terapéutico , Ácido Ascórbico/uso terapéutico , Daño del ADN/efectos de los fármacos , Insecticidas/antagonistas & inhibidores , Linfocitos/efectos de los fármacos , Piretrinas/antagonistas & inhibidores , Vitamina E/uso terapéutico , Animales , Catalasa/sangre , Ensayo Cometa , Suplementos Dietéticos , Membrana Eritrocítica/efectos de los fármacos , Eritrocitos/efectos de los fármacos , Eritrocitos/enzimología , Glutatión Peroxidasa/sangre , Técnicas In Vitro , Insecticidas/toxicidad , Peroxidación de Lípido/efectos de los fármacos , Linfocitos/metabolismo , Masculino , Fragilidad Osmótica/efectos de los fármacos , Piretrinas/toxicidad , Ratas , Ratas Wistar , Superóxido Dismutasa/sangre
14.
Toxicology ; 191(2-3): 233-44, 2003 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-12965126

RESUMEN

Pyrethroids are divided into two groups according to their chemical structures: type I pyrethroids are devoid of a cyano moiety at the alpha-position (i.e. permethrin, PERM), while type II pyrethroids have an alpha-cyano moiety (i.e. cypermethrin, CY). Type I pyrethroids cause a type I poisoning syndrome or "T syndrome", whereas type II pyrethroids induce a type II choreoathetosis syndrome, known as "CS syndrome". The aim of the present work is to compare the effect of PERM and CY on erythrocyte plasma membrane fluidity of rats, treated orally for 60 days with low and high doses of these insecticides. The different modifications induced by pyrethroids on lipid peroxidation, osmotic fragility and the antioxidant enzymes (superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx)) were measured. The data obtained show that PERM, which proved more permeable than CY, produced an increase of fluidity and polarity in the hydrophilic-hydrophobic region of the erythrocyte bilayer even at low doses. Also at high doses, filtering through the membrane more easily, the PERM influenced more markedly the intracellular enzymatic activity, compared with CY, reducing GPx activity and increasing SOD activity. Because of its hydrophilic character, CY limits oxidative damage in the erythrocyte cytosol at high doses.


Asunto(s)
Membrana Eritrocítica/efectos de los fármacos , Insecticidas/toxicidad , Permetrina/toxicidad , Piretrinas/toxicidad , Animales , Peso Corporal/efectos de los fármacos , Catalasa/sangre , Polaridad Celular/efectos de los fármacos , Membrana Eritrocítica/enzimología , Membrana Eritrocítica/metabolismo , Glutatión Peroxidasa/sangre , Peroxidación de Lípido/efectos de los fármacos , Masculino , Fluidez de la Membrana/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Fragilidad Osmótica/efectos de los fármacos , Ratas , Ratas Wistar , Superóxido Dismutasa/sangre
15.
Drug Dev Ind Pharm ; 28(10): 1241-50, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12476870

RESUMEN

Solid dispersions of lonidamine in PEG 4000 and PVP K 29/32 were prepared by the spray-drying method. Then, the binary systems were studied and characterized using differential scanning calorimetry, hot stage microscopy, and x-ray diffractometry. In vitro dissolution studies of the solid dispersed powders were performed to verify if any lonidamine dissolution rate or water solubility improvement occurred. In vivo tests were carried out on the solid dispersions and on the cyclodextrin inclusion complexes to verify if this lonidamine water solubility increase was really able to improve the in vivo drug plasma levels. Drug water solubility was increased by the solid dispersion formation, and the extent of increase depended on the polymer content of the powder. The greater increase of solubility corresponded to the highest content of polymer. Both the solid dispersions and the cyclodextrin complexes were able to improve the in vivo bioavailability of the lonidamine when administered per os. Particularly, the AUC of the drug plasma levels was increased from 1.5 to 1.9-fold depending on the type of carrier.


Asunto(s)
Química Farmacéutica/métodos , Indazoles/farmacocinética , Animales , Área Bajo la Curva , Disponibilidad Biológica , Rastreo Diferencial de Calorimetría , Ciclodextrinas , Indazoles/sangre , Masculino , Polietilenglicoles , Ratas , Ratas Wistar , Difracción de Rayos X
16.
Toxicology ; 175(1-3): 91-101, 2002 Jun 14.
Artículo en Inglés | MEDLINE | ID: mdl-12049839

RESUMEN

The effects of treatment with the synthetic insecticide cypermethrin on plasma membrane fluidity, lipid peroxidation and antioxidant status in rat erythrocytes were investigated. Rats were treated by gavage with a low dose (12.5 mg/kg body weight per day) of cypermethrin in corn oil for 60 days. DPH and TMA-DPH fluorescence anisotropy experiments show that cypermethrin treatment, compared with controls, induced a significant decrease in erythrocyte membrane fluidity measured by DPH, while no changes were observed using TMA-DPH. Cypermethrin treatment also induced a significant increase in the lipid peroxidation, measured by the formation of conjugated dienes. The increased oxidative stress resulted in a significant decrease in the activity of glutathione peroxidase. The results are discussed in terms of preferential localization of cypermethrin in the hydrophobic core of the membrane, where it increases lipid packing and consequently decreases membrane fluidity.


Asunto(s)
Membrana Eritrocítica/efectos de los fármacos , Glutatión Peroxidasa/sangre , Insecticidas/toxicidad , Fluidez de la Membrana/efectos de los fármacos , Piretrinas/toxicidad , Animales , Catalasa/sangre , Membrana Celular/efectos de los fármacos , Membrana Celular/enzimología , Membrana Celular/fisiología , Membrana Eritrocítica/enzimología , Membrana Eritrocítica/fisiología , Polarización de Fluorescencia , Peróxidos Lipídicos/biosíntesis , Masculino , Proteínas de la Membrana/metabolismo , Metahemoglobina/metabolismo , Ratas , Ratas Wistar , Superóxido Dismutasa/sangre
17.
Life Sci ; 70(12): 1427-46, 2002 Feb 08.
Artículo en Inglés | MEDLINE | ID: mdl-11883718

RESUMEN

A series of muscarinic agonists, straight chained, branched, cyclic alkyl and aromatic derivatives of the oxime 1 (demox) was designed with the aim of investigating their activity on muscarinic receptor subtypes. Effects on M1 receptor were assessed functionally by a microphysiometer apparatus, while M2, M3, and M4 receptor potency and affinity were studied on isolated preparations of guinea pig heart, ileum, and lung, respectively. The results suggest that the substitution of a hydrogen with a long side-chain or bulky group generally induces a decrease in potency at M1 and M3 subtypes, while a general increase in this parameter is obtained at M2 subtype. Among the agonists 2-18, compound 4 behaves as a full agonist with a preference for M3 subtype. Moreover, compound 12 is inactive at M1 and M4 receptors while it displays a full agonist activity at M2 and M3 subtypes. Since demox displays a variable response on cardiac M2 receptors regulating heart force, an in-depth inquiry of the functional behaviour of this compound was carried out at M2 receptors. In presence of 10(-11) and 10(-10) M demox, the binding of [3H]-NMS was increased by approximately 30% as a consequence of an increase of the association of [3H]-NMS to membranes; this effect was not observed in presence of a higher concentration of [3H]-NMS. Higher concentrations of demox decreased the binding of [3H]-NMS to heart atrial membranes but significantly retarded the dissociation of this radioligand. Our results suggest that demox may interact with orthosteric and allosteric sites of atrial M2 muscarinic receptor.


Asunto(s)
Muscarina/metabolismo , Agonistas Muscarínicos/farmacología , Oximas/farmacología , Receptores Muscarínicos/metabolismo , Regulación Alostérica , Animales , Sitios de Unión/efectos de los fármacos , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Relación Dosis-Respuesta a Droga , Cobayas , Atrios Cardíacos/efectos de los fármacos , Atrios Cardíacos/metabolismo , Técnicas In Vitro , Masculino , Muscarina/análogos & derivados , Agonistas Muscarínicos/síntesis química , Agonistas Muscarínicos/metabolismo , Contracción Miocárdica/efectos de los fármacos , Oximas/síntesis química , Ratas , Ratas Sprague-Dawley , Receptor Muscarínico M2 , Receptores Muscarínicos/efectos de los fármacos , Relación Estructura-Actividad
18.
Mech Ageing Dev ; 123(5): 491-8, 2002 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-11796134

RESUMEN

Postnatal development in the expression of dopamine D1-like and D2-like receptors was investigated in peripheral blood lymphocytes of male Wistar rats aged 1, 3, 4, 8, 12 and 16 weeks of age by radioligand binding assay techniques. Sample of frontal cortex, striatum and hippocampus were also investigated as reference tissues. The dopamine D1-like receptor antagonist [3H]SCH 23390 and the dopamine D2-like receptor agonist [3H]7-OH-DPAT were used as radioligands. The affinity (K(d)) of [3H]SCH 23390 or of [3H]7-OH-DPAT binding was unchanged in lymphocytes of rats of different age groups. The density (B(max)) of [3H]SCH 23390 binding sites increased from the 1st to the 3rd week of age, remained constant from the 3rd to the 8th week of age, and then increased slightly at 12 and 16 weeks of age. The B(max) value of [3H]7-OH-DPAT binding to lymphocytes increased from the 1st to the 3rd week of age, remained constant from the 3rd to the 4th week, increased again until the 12th week and then plateaued. Dopamine D1-like and D2-like receptor maturation in frontal cortex, hippocampus and striatum revealed an increased receptor density until the 4th week of age and a relative stabilization of receptor density values between the 4th to the 12th week depending on the area considered. Comparatively postnatal maturation of lymphocyte dopamine D1-like receptors displayed a pattern different from that of brain areas investigated, whereas maturation of D2-like receptors displayed a pattern similar to that of striatum. The quantitative and/or qualitative dissimilarities between development of lymphocyte and brain dopamine receptors suggest that from a developmental point of view lymphocyte dopamine receptors probably cannot be considered as a marker of homologous brain receptors.


Asunto(s)
Envejecimiento/metabolismo , Linfocitos/metabolismo , Receptores de Dopamina D1/metabolismo , Receptores de Dopamina D2/metabolismo , Envejecimiento/fisiología , Animales , Benzazepinas/metabolismo , Cuerpo Estriado/crecimiento & desarrollo , Cuerpo Estriado/metabolismo , Agonistas de Dopamina/metabolismo , Antagonistas de Dopamina/metabolismo , Lóbulo Frontal/crecimiento & desarrollo , Lóbulo Frontal/metabolismo , Hipocampo/crecimiento & desarrollo , Hipocampo/metabolismo , Leucocitos Mononucleares/metabolismo , Masculino , Ratas , Ratas Wistar , Tetrahidronaftalenos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...